Search

everythinglearnresearchcommunity

for

Search:↓

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Vitamin A toxicity likely caused the patient's high calcium levels.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Kolaviron and quercetin may help treat prostate issues.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Finasteride in male rats causes liver and metabolic issues in their offspring.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Finasteride may affect male fertility by interfering with specific sperm signaling.